Breakthrough cancer treatment plan ‘could be cure’ for death sentence form of disease
Breakthrough cancer treatment plan ‘could be cure’ for death sentence form of disease
A potential “cure” for a deadly form of cancer could be on the horizon.
Dr Paul Mulholland, a brain cancer expert at University College London, is leading the charge with an experimental treatment that’s showing promise in patients – and it might just be ready for widespread use in five years’ time.
Brain cancer strikes over 12,000 people in Britain annually, and survival rates are grim, with only one in ten living ten years post-diagnosis, often due to late detection and rapid progression of the disease, coupled with a lack of effective treatments.
However, this innovative approach involves using ipilimumab, an immunotherapy drug already employed in skin cancer care, administered intravenously to shrink tumours before surgery, chemotherapy, or radiotherapy can be used to eliminate any remaining cancerous tissue. This could be a game-changer for many battling the illness.
Sara Sjolund, a London entrepreneur, faced her own brain cancer battle at 38, as reported by MailOnline. Despite trying everything from radiotherapy to surgery, nothing stopped her astrocytoma from growing, reports the Express US.
That changed when she joined Dr Mulholland’s trial. Six months in, her tumour has nearly disappeared and is now deemed “inactive” by Dr Mulholland.
